Key facts
- It has raised $130K; the latest was Angel (individual) ($130K) in Nov 2025.
- Notable investors include Anglia Capital Group, University of East Anglia.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Virilitas Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Virilitas Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Virilitas Labs
Operator of a male reproductive health company intended to advance understanding, diagnostics, and support across the fertility journey. The company offers genomics-based assessments, research-driven fertility technologies, and science-backed guidance for men and fertility clinics, enabling individuals and healthcare professionals to improve reproductive insight and enhance outcomes in assisted reproduction.
- Sector
- Healthcare
- HQ
- Norwich, United Kingdom
- Founded
- 2022
- Employees
- 4
- Website
- virilitaslabs.com/
- Ownership
- Privately Held (backing)
Virilitas Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Virilitas Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Virilitas Labs in its N-PORT filings yet. We sweep new filings monthly.